What is Jazz Pharmaceuticals's free cash flow?

Jazz Pharmaceuticals (JAZZ) reported free cash flow of $388.5M in Q1 2026.

How has Jazz Pharmaceuticals's free cash flow changed year-over-year?

Jazz Pharmaceuticals's free cash flow decreased by 6.6% year-over-year, from $415.9M to $388.5M.

What is the long-term trend for Jazz Pharmaceuticals's free cash flow?

Over 4 years (2021 to 2025), Jazz Pharmaceuticals's free cash flow has grown at a 14.6% compound annual growth rate (CAGR), from $750.87M to $1.3B.

Jazz Pharmaceuticals JAZZ Free cash flow

Free cash flow at other companies

AmgenAMGN

$1.48B+50.7%

BiogenBIIB

$594.3M+167%

Bristol-Myers SquibbBMY

$757M-55.3%

BridgeBio PharmaBBIO

——

Ionis PharmaceuticalsIONS

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Revenue$1.1B+19.1%

Operating income$336.6M+702%

Net income$293.1M+417%

EPS (diluted)$4.43+391%

Balance sheet

See full

Cash & equivalents$667.5M-64.1%

Total debt$5.4B-0.1%

Total equity$4.5B+8.6%

Total assets$11.9B+2.8%

Cash flow

See full

Operating cash flow$408.2M-5.0%

CapEx$19.7M+41.7%

Valuation

See full

Market cap$14.11B+54.4%

Enterprise value$18.85B+47.7%

P/S3.2×+0.9×

Profitability

See full

Operating margin-11.9%-28.1pp

Net margin-8.9%-20.5pp

FCF margin28.6%-8.6pp

Returns & leverage

See full

Return on equity-9.1%-21.2pp

Debt / equity1.2×-0.1×

Current ratio2×-1.3×

Where this comes from

Calculated from Jazz Pharmaceuticals’s reported figures.

$408.2Mnet cash from operating−$19.7Mcapital expenditures=$388.5M

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's free cash flow?: Jazz Pharmaceuticals (JAZZ) reported free cash flow of $388.5M in Q1 2026.
How has Jazz Pharmaceuticals's free cash flow changed year-over-year?: Jazz Pharmaceuticals's free cash flow decreased by 6.6% year-over-year, from $415.9M to $388.5M.
What is the long-term trend for Jazz Pharmaceuticals's free cash flow?: Over 4 years (2021 to 2025), Jazz Pharmaceuticals's free cash flow has grown at a 14.6% compound annual growth rate (CAGR), from $750.87M to $1.3B.